about
An Exploratory Investigation of the Association between Clinicians' Attitudes toward Twelve-step Groups and Referral Rates.Evidence-based practices for substance use disordersSterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey.The Classification of Substance Use Disorders: Historical, Contextual, and Conceptual ConsiderationsIntroducing evidence-based practices into substance abuse treatment using organization development methodsThe Place of Adoption in the NIDA Clinical Trials Network.Client and counselor attitudes toward the use of medications for treatment of opioid dependence.Understanding attitudes towards use of medication in substance abuse treatment: A multilevel approach.Adoption of practice guidelines and assessment tools in substance abuse treatmentDirect care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefsDiffusion of contingency management and attitudes regarding its effectiveness and acceptability.Counselor attitudes toward the use of motivational incentives in addiction treatment.Understanding counselors' implementation of tobacco cessation services with patients.Substance abuse treatment counselors and tobacco use: a comparison of comprehensive and indoor-only workplace smoking bansOrganizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers.Counselor attitudes toward the use of naltrexone in substance abuse treatment: a multi-level modeling approachImplementing outside the box: Community-based social service provider experiences with using an alcohol screening and intervention.Views about responsibility for alcohol addiction and negative evaluations of naltrexone.Attachment avoidance and anxiety as predictors of 12-step group engagementThe prescription of addiction medications after implementation of chronic care management for substance dependence in primary careTiming of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysisHow practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an example.Attitudes and beliefs about 12-step groups among addiction treatment clients and clinicians: toward identifying obstacles to participation.Organizational characteristics of drug abuse treatment programs for offenders.Strategies to encourage adoption in multisite clinical trials.Level of analysis issues in assessing treatment beliefs in substance abuse clinics.Organizational Readiness for Change and opinions toward treatment innovationsEfficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trialThe substance abuse counseling workforce: education, preparation, and certification.Empirically supported substance abuse treatment approaches: a survey of treatment providers' perspectives and practicesRural substance use treatment centers in the United States: an assessment of treatment quality by locationAdvancing recovery: implementing evidence-based treatment for substance use disorders at the systems levelThe trouble with morality: the effects of 12-step discourse on addicts' decision-making.Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes.Knowledge and Attitudes About Methadone Maintenance Among Staff Working in a Therapeutic Community.Role of state policies in the adoption of naltrexone for substance abuse treatmentState policy influence on the early diffusion of buprenorphine in community treatment programsPartnerships Among Canadian Agencies Serving Women with Substance Abuse Issues and Their ChildrenCounselor training and attitudes toward pharmacotherapies for opioid use disorder.
P2860
Q24538584-B63C1BA5-CC1A-4AED-97CE-D486A05F16B0Q24614016-4F68F840-C068-4FB7-8FEA-507F8D8AB209Q25255650-CE5DC1CE-39B6-4043-8ED3-E2D6FB8CA1F0Q26739919-A5C00D9B-3875-4CD2-B372-E5F4CBEC0882Q30358275-C5A12670-C5D1-4734-A749-01E427557F0FQ33622979-CDA60488-6474-48E3-A22B-95C4B5544C95Q33763021-8100A0DE-7395-45FF-831E-FDD181E72961Q33791771-D92CB652-7F8F-4E63-8B3F-1DB69F6409AAQ33809288-F1AE9B9E-8F2B-4732-8602-60014B62FB83Q33817446-C709FF88-3FD9-4D7F-9690-7BF7EA4DA501Q34076189-B8053B27-A4AA-40D3-BB02-80C345E5C674Q34222652-B4EF49B8-D6A7-42F5-BC90-9C7329BEC2F3Q34243985-C42DB406-A69C-4149-A687-C36E93C4D74CQ34245034-6275A8DB-71B2-426D-8C97-0EA555A384C0Q34711509-4B21B88B-68C9-4F7B-A4B7-CA010586C729Q34762315-9B14A14E-E19E-4F67-B2B6-AF8279B92030Q35183168-AABB1513-318F-45DC-8F82-F6E5CFA0A11AQ35204253-73482351-8D2F-4650-8F47-F69FABDE2400Q35215526-4AF65EA7-6BB5-4649-8AAE-005E6099C702Q35243514-B8F4DD6D-0A14-42B2-A252-898625B41897Q35577449-C4A34EEF-332E-46CF-8198-51FEC236F336Q35621950-52580F1A-92D0-4326-AC1D-3DC017A5838FQ35679295-36AFBD27-7A86-44A0-A9FE-CF3BA834BD08Q35757960-495D1DB4-5A28-4661-B784-84945808FD08Q35928356-B07EC573-5ED4-4772-A201-25076E23B712Q35950120-E91CEF0B-A708-4F43-9100-39E2CF08897CQ36047706-2FD9B400-B740-4A18-B90A-3355D7B86A49Q36076355-5B3EFFB3-CBCC-470E-B463-B2A50DAB1A79Q36287820-2E9A7DA6-42DF-430F-8512-2AB7FC2210FCQ36364478-68D958E4-B0D7-483C-BAFD-9DDAA898D022Q36640365-E46B8B82-36C9-4FF4-A5E4-EB88AD8342A0Q36643013-D0FA718C-09E7-4334-BDD5-060E6F16C946Q36676519-0C8EB6D1-D38E-4C34-A307-2A05557A3F5DQ36677865-6E28ED0C-5A0F-4563-BB08-34C24690EE2BQ36698474-5E1BDBC4-73F2-497B-858B-0902C9A56085Q36706896-19019944-B10A-4F99-8FC8-7A0002B22633Q36741375-43BF712A-6F2C-4902-8582-B7D479F4ED1CQ36766544-34D19FC9-E72F-46F1-92D8-3766BB713A1DQ36872737-C6F9EB74-0AF1-4DB3-96A7-32E2CEC72430Q36934945-7E4D507A-CB97-4224-9770-F99AADA40452
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Staff beliefs about addiction treatment.
@en
Staff beliefs about addiction treatment.
@nl
type
label
Staff beliefs about addiction treatment.
@en
Staff beliefs about addiction treatment.
@nl
prefLabel
Staff beliefs about addiction treatment.
@en
Staff beliefs about addiction treatment.
@nl
P2093
P1476
Staff beliefs about addiction treatment.
@en
P2093
P356
10.1016/S0740-5472(01)00173-8
P577
2001-07-01T00:00:00Z